Dr. Francis Collins, director of the National Institutes of Health, maintained his support for people under age 65 who have been vaccinated against coronavirus to get a booster shot even after the FDA would not approve it.
"I think the big news is that they did approve the initiation of boosters," Collins said regarding the emergency use authorization for older and at-risk Americans."Remember, they’re taking a snapshot of right now, we’re going to see what happens in the coming weeks. It would surprise me if it does not become clear over the next few weeks that the administration of boosters may need to be enlarged. Based upon the data that we’ve already seen both in the U.S.
The Biden administration had looked at Sept. 20 as a date to begin offering booster shots for all Americans, but the CDC noted that this was pending FDA approval.Collins said he was not sure whether boosters will be recommended for all, pointing to concerns of risks outweighing benefits for younger people, but he maintained that boosters for people under 65 will be approved.
Two FDA officials — Office of Vaccines Research and Review director Marion Gruber and deputy director Phil Krause — are reportedly stepping down from their posts in protest of the Biden administration's push for booster shots.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Advisory Panel Rejects Widespread Pfizer Vaccine Booster ShotsThe 16-2 vote is a blow to the Biden administration's plans for giving booster shots to most Americans.
Read more »
FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine boosterA panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer Inc /BioNTech SE COVID-19 vaccine for people aged 16 and older.
Read more »
U.S. FDA vaccine advisors debate boosters as Biden administration plans rolloutDebate over whether Americans should receive a booster dose of the Pfizer/BioNTech COVID-19 vaccine as planned by the Biden administration moved to a panel of independent expert advisers to the U.S. Food and Drug Administration on Friday.
Read more »
New Hope For ALS Patients After FDA Reverses Course On Possible TreatmentThere’s new hope for ALS patients after the FDA eased its stance on early approval for a promising new treatment. In early clinical trials, the treatment slowed the progression of symptoms from this devastating neurodegenerative disease. From WBUR:
Read more »
F.D.A. Panel Rejects Biden’s Push for Universal COVID-19 Booster ShotsExpert advisers said the Pfizer boosters should be available for people older than 65 and for those at risk of severe illness.
Read more »
The FDA panel decision on vaccine boosters shows the process worked: FauciAfter the Food and Drug Administration's vaccine advisory panel rejected a plan on Friday to offer Pfizer booster shots for all Americans, White House chief medical adviser Dr. Anthony Fauci defended the White House's earlier plan to begin rolling out the shots this month. 'The plan was that we have to be ready to do this as soon as the decision is made and when you have a plan, you put a date on it, and you say we want to be able to get ready to roll out on the week of September the 20th,' Fauci said Sunday. 'So giving that date I don't think was confusing, we needed a date to be able to say, let's get ready to roll this out, pending the decision of the deliberation by the FDA and ultimately the (Centers for Disease Control and Prevention).'
Read more »